United Therapeutics (UTHR) Finished Goods (2010 - 2020)

United Therapeutics has disclosed Finished Goods across 11 years of filings, most recently posting $43.8 million for Q1 2020.

• In Q1 2020, Finished Goods fell 7.98% year-over-year to $43.8 million; the TTM figure through Mar 2020 stood at $43.8 million (down 7.98% YoY), while the FY2019 annual figure was $43.2 million, down 11.29% from the prior year.
• Finished Goods came in at $43.8 million for Q1 2020 at United Therapeutics, up from $43.2 million in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $62.2 million in Q3 2017 to a low of $37.3 million in Q2 2016.
• Average Finished Goods over 5 years is $48.9 million, with a median of $48.7 million recorded in 2018.
• Year-over-year, Finished Goods surged 65.15% in 2017 and retreated 20.58% in 2018.
• Over 5 years, Finished Goods stood at $49.7 million in 2016, then gained by 12.47% to $55.9 million in 2017, then retreated by 12.88% to $48.7 million in 2018, then dropped by 11.29% to $43.2 million in 2019, then rose by 1.39% to $43.8 million in 2020.
• Per Business Quant data, the three most recent Finished Goods figures were $43.8 million in Q1 2020, $43.2 million in Q4 2019, and $45.0 million in Q3 2019.